![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Europe Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)
Market Introduction
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed and used within a single laboratory. These tests can be utilized to estimate or distinguish an extensive assortment of analytes materials such as proteins, chemical compounds like glucose or cholesterol, or DNA, from a specimen received from human anatomy. The expansion of automated in vitro diagnostics (IVD) methods for labs and dispensaries to render precise, and error-free analysis is anticipated to fuel the increment.
![](https://www.theinsightpartners.com//assets/rdimages/25470-img1.jpg)
Get more information on this report :
Market Overview and Dynamics
The European laboratory developed test market is projected to reach US$ 8,988.78 million by 2028 from US$ 5,664.43 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The increasing incidence of cancer and genetic disorders and the growing number of product launches across Europe are factors propelling the laboratory developed testing market. However, the changing regulatory landscape is hampering the growth of the laboratory development test market.
LDTs are developed and used within laboratories and not distributed or sold to other laboratories or healthcare facilities. These tests are designed to overcome the challenge of the unavailability of commercial tests. Many LDTs are genetic tests developed for rare diseases. Thus, the frequency of development and introduction of new LDTs is high.In November 2020, Aditx Therapeutics, Inc received a CLIA certification for AditxtScore laboratory operations for immune monitoring, which allowed them to launch the AditxtScore test to diagnose COVID-19. The increasing emergence of SARS-CoV-2 variants has highlighted the need to identify, trace, and track mutations across the complete viral genome. In January 2021, Eurofins launched the NovaType test for detecting and monitoring new variants of SARS-CoV-2. This RT-PCR assay is clinically validated for identifying B.1.1.7 and B.1.351 variants with a short time. NovaType is already available as an LDT in Germany, and it will be made available in over 50 Eurofins laboratories worldwide for testing patients for COVID-19. Also, the rising demand for personalized medicine is offering significant growth opportunities for the players operating in the European laboratory developed test market.
Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating the pandemic. Many countries are declaring more cases each day than the first wave in 2020. The governments of many countries are working toward scaling up testing capacity, which is further driving the laboratory developed test market. Many market players have launched products to meet the growing demand. For instance, in August 2020, Eurofins Technologies (Luxembourg) launched a range of testing kits for serology-based antibody detection by ELISA of patients exposed to COVID-19. These tests are designed to meet the region-specific requirements for COVID-19. Viracor Eurofins received Food and Drug Administration (FDA) and Emergency Use Authorization (EUA) for its SARS-CoV-2 laboratory developed test. Other Eurofins laboratories have developed alternative RT-PCR options to meet local regulatory obligations and mitigate reagent supply chain issues globally. However, other non-emergency tests witnessed a drop due to lockdown measures and overburdened healthcare institutions.
Key Market Segments
The Europe laboratory developed test market, by type, is segmented into clinical biochemistry, critical care, haematology, microbiology, molecular diagnostics, immunology, and other test types. The haematology segment was sub-segmented into coagulation and hemostasis, hemoglobin testing, blood count testing, and others. The molecular diagnostics segment is expected to hold the largest market share in 2021. However, the haematology segment is anticipated to register the highest CAGR during the forecast period.
The Europe laboratory developed test market, by application, is segmented into academic institutes, clinical research organizations, hospitals laboratory, specialty diagnostic centers, and others. The hospitals laboratory segment is expected to hold the largest market share in 2021. However, the specialty diagnostic centers segment is anticipated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources referred to while preparing the European laboratory developed test market report are the German Diagnostics Industry Association (VDGH), Deutsche Akkreditierungsstelle GmbH (DAkkS), and Spanish Heart Foundation (FEC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe laboratory developed test market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe diltiazem market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe laboratory developed test market.
EUROPE LABORATORY DEVELOPED TEST MARKET SEGMENTATION
By Type
- Clinical Biochemistry
- Critical Care
- Haematology
- Coagulation and Hemostasis,
- Hemoglobin Testing
- Blood Count Testing
- Others
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
By Application
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Others
By Country
- Italy
- France
- Germany
- Spain
- UK
- Rest of Europe
Company Profiles
- Quest Diagnostics Incorporated
- F.HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Guardant Health
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Laboratory Developed Test Market – By Type
1.3.2 Europe Laboratory Developed Test Market – By Application
1.3.3 Europe Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Europe Analysis
6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Europe Analysis
9.1 Europe: Laboratory Developed Test Market
9.1.1 Overview
9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.7 Guardant Health
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 21. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Europe Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Europe and PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
- Quest Diagnostics Incorporated
- F.HOFFMANN-LA ROCHE LTD
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Guardant Health
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.